Screening for diabetic eye disease in Tianjin
Community Screening Study of Diabetic Retinopathy in Tianjin in 2024
This study is testing how common diabetic eye disease is among people with diabetes in Tianjin and looking at ways to improve early detection and treatment to help prevent vision loss.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 18000 (estimated) |
| Sex | All |
| Sponsor | Tianjin Medical University Eye Hospital Academic / other |
| Locations | 1 site (Tianjin, Tianjin Municipality) |
| Trial ID | NCT06478407 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the prevalence and factors influencing diabetic retinopathy among diabetic patients in Tianjin. It involves screening 18,000 patients through fundus examinations and various diagnostic tests, including vision assessments and imaging techniques. The study seeks to enhance detection and intervention capabilities in primary healthcare settings and establish a diabetes prevention and treatment network. Additionally, it emphasizes public education to improve self-management and screening rates, ultimately aiming to reduce blindness caused by diabetic retinopathy.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with diabetes who are residents of Tianjin.
Not a fit: Patients who have not lived in their registered home address for the past six months or those with serious mental illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve early detection and management of diabetic retinopathy, reducing the risk of blindness in diabetic patients.
How similar studies have performed: Other studies focusing on diabetic retinopathy screening have shown success in improving detection rates and patient outcomes, indicating that this approach is supported by prior evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- 1: Clear awareness, barrier-free communication 2: diabetes Exclusion Criteria: * 1: Have left the registered home address 2: In the last 6 months, you have not lived in your place of residence 3: Have a serious mental illness
Where this trial is running
Tianjin, Tianjin Municipality
- Tianjin Medical University Eye Hospital — Tianjin, Tianjin Municipality, China (Recruiting)
Study contacts
- Principal investigator: Xiaorong Li, professor — Tianjin Medical University Eye Hospital
- Study coordinator: Juping Liu, Director
- Email: tydljp@126.com
- Phone: 13752033227
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.